By Steve Kirsch Mar 14, 2021 Fluvoxamine, Proxalutamide, and Ivermectin: 100% success I'm very bullish on two drug combos since it is rare for a single drug to be 100% successful. One Silicon Valley entrepreneur thought he could beat the odds. Dr. Joe Ladapo wrote a brilliant op-ed in the Wall Street Journal, "Too much caution is killing COVID patients." 1:49 We are ignoring the advice of the KOL group and doing nothing. After several failed attempts to stop the progression of his disease, he designed his own protocol for chemotherapy and doctor-shopped to find an oncologist who would give it to him. Compulsive hand washing? Share this post. Personal life. We should be making decisions now based on the evidence on the table today. Today, if we follow the CDC advice, nearly 100,000 people a month will die from COVID. Early research suggests that fluvoxamine, an FDA approved medication for depression and obsessive compulsive disorder, can be an effective early treatment for COVID-19. You can experience serious side effects if you do not pay attention to interactions such as if you are currently on another SSRI of a different type. more time. Refresh. The track management was so impressed, they asked for prescriptions. Can I see your risk-benefit analysis?. And FrameMaker is still a niche product. Ivermectin has been falsely promoted as a covid treatmentbut for those who use the drug legitimately, seeing it become a piece of anti-vaccine misinformation is disconcerting. If you take fluvoxamine, please avoid caffeine while on the drug. Reached by email, the two fluvoxamine investigators denied that there was any effort to suppress their research, and they were cautiously optimistic about their continued study. If you wanna find someone to debate me for ten thousand dollars, or a thousand dollars, Im happy to do that, just for your benefit.. It was tested in coronavirus patients because fluvoxamine has very strong anti-inflammatory properties. In two trials (both published studies in peer reviewed journals with Editor's Choice in both cases), the drug had a 100% effect size in protecting against hospitalization from the respiratory symptoms from COVID. ). Most recent articles first. 90,000 people will die in the next 3 weeks alone if we continue to ignore this drug that has caused no harm. There are now 5 independent observational studies that show that the drug works (2 in France, 1 in Germany, 2 in the US). One user reported dilated pupils and increased heart rate (which could be nerves about the dilated pupils). The results would, eventually, set Kirsch on a collision course with the scientific establishment. My crime? Several other trials around the world are in the final stages, too. The ICER independent review showed fluvoxamine is more effective than Molnupiravir: Read this article I wrote about using fluvoxamine correctly for COVID. Should Steve Kirsch Be Allowed To Speak on Campus about His Eccentric But I know something else that few other people know, thanks to a source at the NIH: the NIH was planning to approve fluvoxamine months ago, but they got a call from the FDA telling them not to. Completely avoid caffeine, alcohol, tylenol, and benadryl. A very short op-ed arguing for using fluvoxamine against COVID. If you were drowning and we had no known standard of care to save your life and someone had a life preserver which worked 160 times in a row, should we throw them the life preserver or let them drown because we aren't absolutely sure the life preserver's benefit > risk (since just because it worked 160 times in a row and there is a 99.99% chance the effect didn't happen by chance, we could have just gotten lucky). In May, all 12 members of CETFs scientific advisory board resigned, citing his alarming dangerous claims and erratic behavior. Over the summer, the conflict reached his most recent startup, M10. I also think it makes a lot of sense to look for pre-existing drugs that can help treat covid symptoms. Fluvoxamine, Proxalutamide, and Ivermectin: 100% success Independent appraisal committee votes 11-2 that the evidence is not adequate to demonstrate a net health benefit for molnupiravir over symptomatic care alone; Paxlovid and fluvoxamine receive more favorable votes. Pretty much nothing changed when the Phase 3 trial confirmed fluvoxamine worked. Some countries dont have fluvoxamine so this is the alternative. They were all given the drug soon after symptoms and the placebo group was pure in that they were not taking any COVID drugs. No one has been able to come up with an example where phase 2 + this level of evidence resulted in a failure of Phase 3. Steve Kirsch and the Seduction of Simplicity - McGill University Has it really been 25 years, a whole quarter of a century? Pennsylvania Senator Doug Mastriano Hosts Expert Panel on Medical Thanks to the volumes of data and information provided by pharmaceutical companies and regulators, as well as large numbers of trials from independently funded research groups around the world, I now trust that theyre safe for the vast majority of adults. So why would we wait when lives are being lost? The data we have today with just 2 clinical trials (RCT and confirmatory RWE) is compelling. Most doctors wont use it until NIH greenlights it, no matter what the science says. While these are stunning results, less than a dozen doctors in the US are prescribing fluvoxamine today. They immediately ruled out the vaccine, because the vaccine is, quote, safe.. The WashU Phase 3 study hasnt been disclosed yet, but they had compliance problems with their patients this time around (phase 2 was local so the patients got the drug early and also were very compliant and the placebo group was truly taking nothing). The group who declined the drug were very sick with 12.5% requiring hospitalization and one died. . The NIH picks the drug that makes the most money for the drug companies regardless of long-term safety Molnupiravir! Zero. CETF funded David Boulware's trials on hydroxychloroquine and the Phase 2 and Phase 3 fluvoxamine trials, among many other research projects. The reason that it isnt used is because the medical community ignores evidence-based medicine principles. But they dont want their names used. On January 22, 2021, thirty key opinion leaders (KOL) from NIH, CDC, and leading academic institutions met to review the evidence for using fluvoxamine for treating COVID. Be warned!. Fluvoxamine, Proxalutamide, and Ivermectin: 100% success I'm very bullish on two drug combos since it is rare for Read More The best COVID treatments for hospitalized patients Seven treatments for hospitalized COVID patients with very high success rates. Thirty minutes past the end of our scheduled time, he dropped his phone in the cupholder of his Tesla so that he could keep talking while he ran an errand. Los Altos Hills resident touts fluvoxamine as COVID-19 treatment The Lancet paper showed that if you were treated early enough and took the drug as prescribed (it only works if you take it), it was shown to reduce your chance of death by 12X making it far more effective than any other drug for COVID. As Kirsch has gone deeper into the anti-vaccine scene, many professional associates have increasingly distanced themselves from him. of the 'intellectual dark web '" and allowed him to access a "large and receptive audience to his claims about a fluvoxamine conspiracy". Former Silicon Valley tech executive Steve Kirsch, a philanthropist and Substack author who created the COVID-19 Early Treatment Fund (CETF) to fund researchers working on repurposed drugs, including fluvoxamine, which reduces death from COVID by a factor of 12. Why fluvoxamine isnt used. He's discovered a common medication that's highly effective in minimizing the impacts of COVID-19 - two studies have proven so. Flavio Cadegiani and Steve Kirsch's studies didn't make the cut. Their Lack of action. This is a more comprehensive look at the key evidence supporting fluvoxamine: Hear from the doctors who did the studies directly as well as the Dean of Medicine at Emory University: List of the best evidence-based COVID treatment options. In 2016, it was the 135th most-prescribed medication in the United States, with more than 4 million prescriptions. (PDF) 9th International Congress on Psychopharmacology - academia.edu The premise made sense: Most experts were predicting vaccines would take years, while finding helpful drugs with known safety profiles could shortcut the approval process. Those who know Kirsch say this is a typical tactic. Today, if we follow the CDC advice, nearly 100,000 people a month will die from COVID. You can help by bringing this document to your doctor's attention. It was recommended back in January 2021 by a key opinion leader (KOL) panel to be used, but it took a year for, because they were rejected by 10 journals. Dr. Seftel is an NIH-funded researcher and an NIH reviewer. People who report not tolerating the drug are typically prescribed too high a dose. Steve Kirsch: Vaccine Killing Millions, Treatments, VAERS, 5-Month Here are the key things you should know about fluvoxamine for COVID: It works. Although the average effect size is 100% with a p-value of <.0001, The Fisher exact test on the combined data suggests that there is a 95% chance that the effect size is at least a 75% reduction in hospitalization rate. Steve Kirsch cut the check, which allowed Dr. Lenze to finish recruiting the 152 patients he needed for his trial. By Steve Kirsch in fluvoxamine Feb 14, 2021 The case for fluvoxamine for treating COVID-19 A very short op-ed arguing for using fluvoxamine against COVID. committee votes 11-2 that the evidence is not adequate to demonstrate a net health benefit for molnupiravir over symptomatic care alone; Paxlovid and fluvoxamine receive more favorable votes, This site requires JavaScript to run correctly. But the confusion provided a fertile breeding ground for skeptics. Were having trouble saving your preferences. While Fauci was crafting national pandemic policies, Fauci's wife [Christine Grady, Chief Bioethicist, NIH] was back stopping [them]." Report coming soon. The alarming article cited the claims of two anti-vaxxers, Steve Kirsch and Dr. Robert Malone. . Most recent articles first. A few months ago, Kirsch suddenly stopped promoting hydroxychloroquineeven scrubbing it from the CETFs official list of trials it has funded. CETF Founder Steve Kirsch discusses why we can't wait for a COVID-19 vaccine, the importance of researching existing drugs now, and our work to raise funds for outpatient trials to identify effective . Always be self aware when using fluvoxamine. If you ask your doctor for any evidence that fluvoxamine doesnt work or is harmful (like a DB-RCT which is the only thing they trust), they will show you nothing. One of the drugs, Fluvoxamine, showed a 30 . If you do have a side-effect, it is usually mild nausea which goes away when you stop taking the drug. He has made millions from these projects, even if they have not turned him into a household name. Steve Kirsch reported that doctors commonly say (of fluvoxamine), "This is the most powerful drug in my arsenal. Read More fluvoxamine The Fluvoxamine FAQ Note that some of these articles are inaccurate. Steven Todd Kirsch is an American entrepreneur. The choice couldn't be more clear cut.

Congressional Casework Quizlet, Articles S